Track Neogen Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Neogen Corporation NEOG Open Neogen Corporation in new tab

9.41 USD
EPS
-2.78
P/B
0.92
ROE
-25.25
Beta
1.95
Target Price
11.67 USD
Neogen Corporation logo

Neogen Corporation

🧾 Earnings Recap – Q4 2025

Neogen Corporation's fourth quarter results reflect ongoing challenges in the Food Safety segment, compounded by market and regulatory pressures. However, strategic initiatives in pathogen detection and operational simplification signal a focused path forward.

  • Food Safety end market conditions worsened due to ongoing inflation pressures, leading to lower production volumes among food producers.
  • Neogen launched the Listeria Right Now assay on its MDS platform, enhancing pathogen detection capabilities.
  • The Board is transitioning the CEO role to better align with future growth potential amidst a regulatory environment prioritizing food safety.
  • Core revenue in the Animal Safety segment has faced headwinds, but signs of improvement in net farm incomes could support recovery.
  • Ongoing divestiture processes aim to streamline operations and prioritize core business areas for improved focus and deleveraging.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateApril 7, 2026
EPS-2.78
Book Value9.68
Price to Book0.92
Debt/Equity37.78
% Insiders0.938%
Growth
Revenue Growth-0.03%
Estimates
Forward P/E27.56
Forward EPS0.32
Target Mean Price11.67

DCF Valuation

Tweak assumptions to recompute fair value for Neogen Corporation (NEOG)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Neogen Corporation Logo Neogen Corporation Analysis (NEOG)

United States Health Care Official Website Stock

Is Neogen Corporation a good investment? Neogen Corporation (NEOG) is currently trading at 9.41 USD. Market analysts have a consensus price target of 11.67 USD. This suggests a potential upside from current levels.

Earnings Schedule: Neogen Corporation is expected to release its next earnings report on April 7, 2026. The market consensus estimate for Forward EPS is 0.32.

Investor FAQ

Does Neogen Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Neogen Corporation?

Neogen Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be April 7, 2026. The company currently has a trailing EPS of -2.78.

Company Profile

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Exchange Ticker
NMS (United States) NEOG

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion